30 completed, 17 active not recruiting, 15 recruiting, 8 terminated. 27 Not applicable, 24 Phase 2, 17 Phase 1, 3 Early Phase 1, 2 Phase 3.
Follow Cervical Carcinoma: new trials by email Literature Review of Cervical Carcinoma trials Research Report on Cervical Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy Educational Intervention, Interview, Flyte Medical Device Usage and Evaluation - Cervical Carcinoma, Endometrial Carcinoma | Not applicable | Recruiting | Mayo Clinic | 44 | 2026-08-20 | 2026-08-31 |
| A Community Based Intervention to Improve Cervical Cancer Screening Among Women in the Hispanic and East African Immigrant Community HPV Self-Collection, Informational Intervention, Interview - Cervical Carcinoma | Not applicable | Recruiting | Mayo Clinic | 118 | 2026-08-15 | 2026-10-22 |
| Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia TICHILALECH ECHO - Cervical Carcinoma, Human Papilloma Virus (HPV) | Not applicable | Enrolling by invitation | Albert Einstein College of Medicine | 60 | 2026-06-24 | 2026-07-01 |
| Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer Biospecimen Collection, Prasterone, Survey Administration - Anal Carcinoma, Cervical Carcinoma | Phase 2 | Recruiting | Ohio State University Comprehensive Cancer Center | 25 | 2026-03-12 | 2026-04-21 |
| Neoadjuvant Lymph Node Targeted Immunotherapy in Cervical Cancer: a Feasibility Study (NEOLYNC) Nivolumab - Cervical Carcinoma | Phase 1 | Recruiting | University Medical Center Groningen | 12 | 2026-01-05 | 2026-06-17 |
| The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas Cancer Therapeutic Procedure, Questionnaire Administration - Amyloidosis, Basal Cell Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 27 | 2025-12-18 | 2026-09-30 |
| Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases. Ovarian Carcinoma, Cervical Carcinoma | Not yet recruiting | National Cancer Institute, Naples | 130 | 2025-12-01 | 2025-12-05 | |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Recruiting | National Cancer Institute (NCI) | 500 | 2025-11-24 | 2026-07-31 |
| Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer Cervical Carcinoma | Recruiting | Tata Memorial Hospital | 110 | 2025-10-25 | 2026-02-04 | |
| Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening Best Practice, Communication Intervention, Electronic Health Record Review - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Enrolling by invitation | Mayo Clinic | 500 | 2025-10-07 | 2026-06-09 |
| Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer Sintilimab, Concurrent chemo-radiotherapy - Cervical Carcinoma | Phase 2 | Not yet recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 180 | 2025-09-01 | 2025-09-22 |
| Transmission of Oncogenic HPV Infection Among Families Human Papilloma Virus (HPV), Cervical Carcinoma | Not yet recruiting | Tampere University Hospital | 700 | 2025-08-01 | 2025-06-25 | |
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-08-01 | 2026-10-20 |
| A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations ATV-1601, ATV-1601 + Fulvestrant - Advanced Solid Tumors, Breast Cancer | Phase 1 | Active not recruiting | Atavistik Bio, Inc | 134 | 2025-07-29 | 2026-08-07 |
| Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers For each enrolled patient, the sample described below will be collected as specific intervention intended for research purposes: - Urothelial Carcinoma, Renal Cancer | Not applicable | Recruiting | Institut Claudius Regaud | 450 | 2025-07-23 | 2026-06-15 |
| Validation of Vaginal Self-Sampling With the Abbott Multi-Collect Swab for HPV Screening in Women Aged 30 to 64 Years Abbott Multi-Collect Specimen Collection Swab - Human Papilloma Virus, Human Papilloma Virus Related Cervical Carcinoma | Completed | AML | 1000 | 2024-09-19 | 2026-08-17 | |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Active not recruiting | National Cancer Institute (NCI) | 500 | 2024-09-13 | 2026-07-07 |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Active not recruiting | National Cancer Institute (NCI) | 500 | 2024-09-11 | 2026-07-07 |
| HPV Vaccine, Imiquimod, and Metformin Combination Trial HPV vaccine, Imiquimod, and metformin combination therapy - Cervical Carcinoma, Vaginal Carcinoma | Phase 2 | Recruiting | Baylor College of Medicine | 85 | 2024-08-23 | 2024-11-13 |
| Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers Best Practice, Cilostazol, Cryocompression Therapy - Cervical Carcinoma, Fallopian Tube Carcinoma | Phase 2 | Recruiting | Emory University | 70 | 2024-08-01 | 2026-08-27 |
Showing 20 of 85. Sign in to see all of them.
Uterine Cervical Neoplasms (85) · Endometrial Neoplasms (20) · Ovarian Neoplasms (15) · Papillomavirus Infections (13) · Vulvar Neoplasms (13) · Breast Neoplasms (12) · Vaginal Neoplasms (11) · Melanoma (10) · Colorectal Neoplasms (9) · Anus Neoplasms (8) · Carcinoma, Hepatocellular (8) · Carcinoma, Renal Cell (8) · Carcinoma, Transitional Cell (7) · Pancreatic Neoplasms (6) · Prostatic Neoplasms (6)
Female Urogenital Diseases (85) · Female Urogenital Diseases and Pregnancy Complications (85) · Genital Diseases (85) · Genital Diseases, Female (85) · Urogenital Diseases (85) · Uterine Cervical Diseases (85) · Uterine Diseases (85) · Neoplasms by Site (84) · Urogenital Neoplasms (84) · Genital Neoplasms, Female (83) · Neoplasms (81) · Uterine Neoplasms (81) · Endocrine System Diseases (22) · Neoplasms by Histologic Type (22) · Endocrine Gland Neoplasms (21)
Cisplatin (6) · Specimen Handling (6) · Educational Status (5) · Interviews as Topic (5) · pembrolizumab (5) · Colposcopy (4) · Early Intervention, Educational (4) · Human Papillomavirus DNA Tests (4) · Methods (4) · Paclitaxel (4) · Practice Guidelines as Topic (4) · Radiation (4) · Standard of Care (4) · Carboplatin (3) · Magnetic Resonance Spectroscopy (3)
National Cancer Institute (NCI) (10) · Ohio State University Comprehensive Cancer Center (8) · Mayo Clinic (6) · Xencor, Inc. (3) · Albert Einstein College of Medicine (2) · Institut Claudius Regaud (2) · Jonsson Comprehensive Cancer Center (2) · M.D. Anderson Cancer Center (2) · OHSU Knight Cancer Institute (2) · Sun Yat-sen University (2) · Thomas Jefferson University (2) · AML (1) · Advenchen Laboratories, LLC (1) · Atavistik Bio, Inc (1) · Azienda Policlinico Umberto I (1)
United States (54) · China (12) · Italy (7) · Spain (5) · France (4) · Puerto Rico (3) · United Kingdom (3) · Belgium (2) · Germany (2) · Netherlands (2) · Canada (1) · Costa Rica (1) · Czechia (1) · Denmark (1) · Ethiopia (1)
Vikrant V Sahasrabuddhe (4) · Allison Quick, MD (2) · Jeremie Calais (2) · Paul Reiter, PhD (2) · Aimee Kreimer (1) · Alexander Shoushtari (1) · Allison E. Garda, M.D. (1) · Allison M Quick, MD (1) · Amanda S Bruegl (1) · Antonio T Fojo, M.D. (1) · Arvind Nageshwara Dasaru, MD (1) · Benjamin Thompson, MD, PhD (1) · Breanne Lott, PhD (1) · Brittany A. Strelow, DSMc, PA-C (1)
PMID 26586415, PMID 27869293, PMID 28285845, PMID 28332888, PMID 30461597, PMID 30603797, PMID 30943124, PMID 31264912, PMID 31682550, PMID 31822399, PMID 31980466, PMID 32334034, PMID 32359091, PMID 32414376, PMID 32463741, PMID 32610059, PMID 32919526, PMID 33048619, PMID 33271093, PMID 33358206, PMID 33433743, PMID 33836153, PMID 34717616, PMID 34882500, PMID 34990208, PMID 35114169, PMID 35133871, PMID 35138919, PMID 35361487, PMID 35588692, PMID 35680043, PMID 35709811, PMID 35727633, PMID 35777186, PMID 35835611, PMID 36200668, PMID 36351402, PMID 36748723, PMID 37053535, PMID 37185961, PMID 37322121, PMID 37442868, PMID 37934000, PMID 38222312, PMID 38591867, PMID 38719544, PMID 39445831, PMID 39666929, PMID 39693587, PMID 39913886
P01CA229143 (2), 2015 (1), 2025 (1), P30CA006927 (1), P30CA013330 (1), P30CA042014 (1), P30CA138292 (1), R01CA157469 (1), R01CA181452 (1), R21CA249870 (1), U01CA294799 (1), U10CA101165 (1), U10CA180820 (1), U10CA180821 (1), U24CA196172 (1)